Swissmedic Says No Room for Misleading Claims Amid Media Clash Over Weight-Loss Drugs

 
• By Anabel Costa-Ferreira

Recent court cases initiated by the Swiss medicines regulator against “unbalanced” media reporting on GLP-1 drugs for weight loss highlights its zero tolerance for any form of misinformation that compromises patient safety.

Swissmedic has labeled some media reports on weight loss drugs as unauthorized ads (Shutterstock)

More from Marketing & Advertising

More from Compliance